The CMCiB, ready for advanced research on SARS-CoV-2
The Centre for Comparative medicine and Bioimage (CMCiB) of the IGTP has its animal biocontainment laboratories level 3 (BSL3) ready to receive new projects related to the study of the SARS-CoV-2 virus. These facilities are biological containment areas designed for work on microorganisms that cause infectious diseases, especially those with a high risk of transmission through the diffusion of aerosols.
The BCLL3 spaces at the CMCiB are fully functioning and are already hosting research using animal models for tuberculosis and AIDS. Since 1 September laboratories within the area have been specially prepared to work with SARS-CoV-2 and to house animal models susceptible to the virus and process the samples arising from them. To complete this process specialized training sessions for the research staff who will work in these areas are now in the phase of completion.
The first projects on SARS-CoV-2 using animal models are due to start this September. This is another step towards understanding the virus and developing reliable vaccines.